CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 680 enrolled
Drug / intervention
fluticasone furoate, fexofenadinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00502775
NCT00502775Phase 4Completed
CompareCT.gov

A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis

GlaxoSmithKline·interventional·Posted Jul 18, 2007·Updated Dec 9, 2016

In Brief

A Phase 4 clinical trial evaluating fluticasone furoate, fexofenadine for Rhinitis, Allergic, Seasonal. Completed, enrolled 680 participants across 42 sites.

Detailed Summary

The primary objective of the study is to compare nighttime symptom relief of fluticasone furoate nasal spray versus oral fexofenadine

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRhinitis, Allergic, Seasonal
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 18, 2007
Enrollment StartAug 1, 2007
Primary CompletionNov 1, 2007
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 19.0 years ago

Interventions

fluticasone furoate, fexofenadinedrug